Citigroup’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-28,900
Closed -$3.87M – 5733
2024
Q2
$3.87M Buy
+28,900
New +$5.47M ﹤0.01% 1826

Other funds holding INSP

Citigroup's INSP Position: Q3 2026 in Review

Citigroup reduced its Inspire Medical Systems (INSP) stake by 25% in Q3 2026, selling an estimated $1.16M and leaving 58,345 shares worth $4.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Citigroup first reported a position in INSP in Q2 2018 and has held it in 34 quarters since. The position peaked at $6.69M in Q2 2025. 308 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Citigroup held 58,345 shares of Inspire Medical Systems worth $4.05M as of Q3 2026.
  • Citigroup sold 19,435 Inspire Medical Systems shares in Q3 2026, an estimated $1.16M.
  • Inspire Medical Systems made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #2269 holding.
  • Citigroup first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 34 quarters since.
  • Citigroup's Inspire Medical Systems position peaked at $6.69M in Q2 2025.
  • 308 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.